Press release from Business Wire
Incyte to Report Fourth Quarter/Year-End 2013 Financial Results on February 12
Monday, January 27, 2014
Incyte to Report Fourth Quarter/Year-End 2013 Financial Results on February 1208:00 EST Monday, January 27, 2014
WILMINGTON, Del. (Business Wire) -- Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter/year-end 2013 financial results conference call for 8:30 a.m. ET on Wednesday, February 12, 2014. The schedules for the press release and conference call are as follows:
|-- Q4 & YE 2013 Press Release:||February 12, 2014 at 7:00 a.m. ET|
|-- Q4 & YE 2013 Conference Call:||February 12, 2014 at 8:30 a.m. ET|
|-- Domestic Dial In Number:||877-407-8037|
|-- International Dial In Number:||201-689-8037|
|-- Conference ID #||13574983|
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13574983.
The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications